Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
Part of paid clinical trials in Dothan, Alabama.
- Sponsor
- Alkermes, Inc.
- Study ID
- NCT04987229
- Phase
- PHASE3
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- OLZ/SAM — DRUGOlanzapine and Samidorphan fixed dose coated tablet taken once daily
Study Details
To evaluate the long-term safety and tolerability of OLZ/SAM in pediatric subjects with schizophrenia or Bipolar I disorder
Key Dates
- Start date
- Oct 22, 2021
- Status verified
- Jun 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 236 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: All subjectsAll subjects will receive OLZ/SAM at a dose determined by the Investigator and based on the olanzapine dosing received in the antecedent study (ALKS 3831-A311 or ALKS 3831-A312 ENLIGHTEN-Youth)
Primary Outcome Measure
Incidence of adverse events [ Time Frame: Up to 52 weeks ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alkermes Investigational Site | Dothan | Alabama | 36303 | - |
| Alkermes Investigational Site | Little Rock | Arkansas | 72204 | - |
| Alkermes Investigational Site | Stanford | California | 94305 | - |
| Alkermes Investigational Site | Washington D.C. | District of Columbia | 20010 | - |
| Alkermes Investigational Site | Miami Lakes | Florida | 33016 | - |
| Alkermes Investigational Site | Decatur | Georgia | 30030 | - |
| Alkermes Investigational Site | Chicago | Illinois | 60611 | - |
| Alkermes Investigational Site | Indianapolis | Indiana | 46202 | - |
| Alkermes Investigational Site | Saint Charles | Missouri | 63304 | - |
| Alkermes Investigational Site | Lincoln | Nebraska | 68526 | - |
| Alkermes Investigational Site | Cincinnati | Ohio | 45229 | - |
| Alkermes Investigational Site | West Chester | Ohio | 45069 | - |
| Alkermes Investigational Site | Richmond | Virginia | 23220 | - |
| Alkermes Investigational Site | Everett | Washington | 98201 | - |
Find similar trials in Dothan, AL
By condition
By specialty
Related Studies
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Imaging Synapses With [11C] UCB-J in the Human BrainPHASE1 · Recruiting · Davidzon, Guido, M.D. · Palo Alto, California
- Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in SchizophreniaRecruiting · University of California, Davis · Sacramento, California
- Normobaric Oxygen Therapy for Individuals With First-Episode PsychosisRecruiting · Nicholas Breitborde · Columbus, Ohio